drugset / Trial / NCT03438435

Fluorescence QRH-882260 Peptide Imaging in the Bile Duct

NCT03438435 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

Patients undergoing ERCP procedure with biliary stricture will have epithelial mucosa labeled with QRH-882260 fluorescence peptide that binds to EGFR. A custom mini-cholangioscope will be used to image the luminal surfaces of the biliary duct that are exposed to the fluorescence peptide. The images will be recorded and analyzed for relative fluorescence pattern and intensity and correlated to patient diagnosis and clinical outcomes.

Timeline

Start
2019-04-22
Primary completion
2020-08-21
Completion
2020-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject QRH-882260 Heptapeptide Peptide 5 ml Topical

Indications